João Pedro Ferreira
Inserm(FR)Universidade do Porto(PT)French Clinical Research Infrastructure Network(FR)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Diabetes Treatment and Management, Cardiovascular Function and Risk Factors, Hormonal Regulation and Hypertension, Pancreatic function and diabetes
Most-Cited Works
- → Empagliflozin in Heart Failure with a Preserved Ejection Fraction(2021)4,371 cited
- → SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials(2020)1,334 cited
- → The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial(2022)836 cited
- → Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials(2020)627 cited
- → Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction(2020)414 cited
- → Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status